Mytos

About Mytos

Mytos is a company focused on scaling regenerative medicine to millions of patients through automated manufacturing solutions. Their mission is to provide scalable, consistent, and cost-effective production for regenerative medicine using their proprietary iDEM™ automation technology.

Products & Services

iDEM™ Technology:An automation technology that enables clinical-stage companies to automate cell culture processes without compromising biology, reducing labor and cleanroom footprint by up to 10x, ensuring consistent quality at scale, and offering a closed, reliable system.

Automated CDMO Services:A Contract Development and Manufacturing Organization (CDMO) service powered by iDEM™ technology, providing scalable manufacturing for regenerative medicine with up to 50% cost reduction compared to manual CDMOs, no suite fees, and support from process development to regulatory compliance.

Specialties

Automated Cell Culture Regenerative Medicine Manufacturing CDMO Services Cell Therapy Production

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 19000000 MR: - FA: $19M FAN: 19000000	D: 2023-11-30 FD: 2023-11-30	3 investors

Series A Latest

2023-11-30

$19.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ali Afshar

CEO | Co-Founder

I

Ignacio Willats

Co-Founder

J

Justin Chan

Head of Engineering

C

Celso Milne

Chief of Staff

S

Stephen Weston

Biology Lead

J

Jordina Casanova Vilar

Senior Scientist

View 35 more team members with Pro

Unlock Full Team Directory

Recent News

Mytos Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised